- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 9, 2025 | 48.47M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $0 |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $4.95M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $50.18M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $37.63M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.04M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.44M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $71.43M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $60.92M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $83.1M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $79.21M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $15.41M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $17.59M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $17.48M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $19.9M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 26.26M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$14.41M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$62.36M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$115.44M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.03 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.03 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $2.84M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $5.52M |
| Net Income | Q1 2025 · Mar 31, 2024 | $757K |
| Operating Income | Q1 2025 · Mar 31, 2024 | $7.24M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $1.95M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $1.31M |
| Revenue | Q1 2025 · Mar 31, 2024 | $3.27M |